Fig. 3. Typical protocol for oral and sublingual immunotherapy

Slides:

Advertisements

Similar presentations

Management of Food Allergies: Beyond avoidance, what does the future hold? Stanley Fineman, MD, MBA Adjunct Associate Professor, Department of Pediatrics.

Advertisements

Fadhel Saleh 1, Rabab A. Hussain 2, Fadheela A. Saleh 2

Fig. 3. Smoothed spline plot of percentage of days with asthma control by treatment group versus smoking history (in pack years; A) and FEV1 percent predicted.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Immunotherapy for Food Allergy: Are We There Yet?

Allergen immunotherapy: A practice parameter third update

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus.

Corinne A. Keet, MD, MS, Pamela A

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy Satya D. Narisety,

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses Stephen R. Durham,

Alison M. Hofmann, MD, Amy M. Scurlock, MD, Stacie M

Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy Michael Kulis, PhD, Katie.

Advances in food allergy in 2015

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses Stephen R. Durham,

Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity Christophe Dupont, MD, PhD,

Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A

Food Allergy: Common Causes, Diagnosis, and Treatment

Work Group report: Oral food challenge testing

Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy Julie Wang, MD, Stacie M. Jones,

Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial Thomas R. Abrahamsson, MD, Ted Jakobsson, MD,

Advances in Peanut Allergen Immunotherapy

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled.

Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology–European Academy of Allergy and.

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy Robert A.

Sublingual immunotherapy for hazelnut food allergy: A randomized, double-blind, placebo-controlled study with a standardized hazelnut extract Ernesto.

Badrul A. Chowdhury, MD, PhD

Advances in Peanut Allergy

NAEPP Expert Panel Report

Oral phenylephrine: An ineffective replacement for pseudoephedrine?

Noninjection routes for immunotherapy

A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy Justin M. Skripak, MD, Scott D. Nash, MD, Hannah.

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus.

Administration of a probiotic with peanut oral immunotherapy: A randomized trial Mimi L.K. Tang, PhD, Anne-Louise Ponsonby, PhD, Francesca Orsini, MSc,

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy Satya D. Narisety,

Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study Jeremy Waldram, MD, Kristen Walters,

Legends in allergy: Philip S. Norman and Lawrence M

Thomas B. Casale, MD, Tmirah Haselkorn, PhD, Christina E

News & Notes Journal of Allergy and Clinical Immunology

Anna Nowak-Wegrzyn, MD, Katherine A. Bloom, MD, Scott. H

Phillip Lieberman, MD, David Golden, MD

Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy Yamini V. Virkud, MD, MA, MPH, A. Wesley Burks,

Clinical characteristics of soybean allergy in Europe: A double-blind, placebo-controlled food challenge study Barbara K. Ballmer-Weber, MD, Thomas Holzhauser,

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.

Insect sting allergy and venom immunotherapy: A model and a mystery

Jennifer S. Kim, MD, Anna Nowak-Węgrzyn, MD, Scott H

Corinne A. Keet, MD, MS, Pamela A

News & Notes Journal of Allergy and Clinical Immunology

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

House dust mite sublingual immunotherapy: Results of a US trial

Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo-controlled study Giovanni B. Pajno,

Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down Eric D. Bateman, MD, Loretta Jacques, PhD,

Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy Julie Wang, MD, Stacie M. Jones,

Bruce G. Bender, PhD, Alex Pedan, PhD, Laleh T. Varasteh, RPh, MSF

Risk of oral food challenges

Xiu-Min Li, MD, LaVerne Brown, PhD

Esophageal eosinophilia caused by milk proteins: From suspicion to evidence based on 2 case reports Soledad Terrados Cepeda, MD, Dario Antolin-Amerigo,

Fig. 2. Putative mechanisms of oral tolerance induction in the gut

Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen- induced asthmatic reactions Emmerentia van Schalkwyk, MBChB, K. Strydom,

Oral peanut immunotherapy in children with peanut anaphylaxis

Dietary baked egg accelerates resolution of egg allergy in children

Footnotes1 Journal of Allergy and Clinical Immunology

Larry C. Borish, MDa, Harold S

Update on risk factors for food allergy

Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.

Specific oral tolerance induction in children with very severe cow's milk–induced reactions Giorgio Longo, MD, Egidio Barbi, MD, Irene Berti, MD, Rosanna.

Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitization Edwin H. Kim, MD, J. Andrew Bird, MD, Michael Kulis,

News & Notes Journal of Allergy and Clinical Immunology

Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo- controlled study Lone Nielsen, MD, Claus R. Johnsen, MD, Holger.

Food protein–induced enterocolitis syndrome: Not so rare after all!

Presentation transcript:

Fig. 3. Typical protocol for oral and sublingual immunotherapy Fig. 3. Typical protocol for oral and sublingual immunotherapy. Initial doses of OIT and SLIT are generally given under medical supervision. Initial dose escalation day(s) starting at subthreshold dose with increasing doses given every 30 minutes over several hours is more common for OIT than for SLIT. Highest tolerated dose given under observation is then continued daily at home, and increased every 1 to 2 weeks under supervision during the build-up phase. The dose achieved at the end of the build-up is continued daily during a maintenance phase. After a few months or years of maintenance, double-blind placebo-controlled food challenge (DBPCFC) to the food is performed to assess for desensitization. Daily dosing may then be discontinued for a period of 4–12 weeks and reintroduced during DBPCFC, to assess sustained tolerance (SU). Reprinted from Journal of Allergy and Clinical Immunology: In Practice (Volume 5), Gernez Y and Nowak-Wegrzyn A, “Immunotherapy for Food Allergy: Are we there yet?”, Page 253, 2017, with permission from Elsevier. Fig. 3. Typical protocol for oral and sublingual immunotherapy. Initial doses of OIT and SLIT are generally given under medical supervision. Initial dose escalation day(s) starting at subthreshold dose with increasing doses given every 30 minutes over several hours is more common for OIT than for SLIT. Highest tolerated… Allergy Asthma Immunol Res. 2018 May;10(3):189-206. https://doi.org/10.4168/aair.2018.10.3.189